A biotechnology company pioneering the development of tissue-targeted genetic medicines has announced their three new executive leaders and headquarter relocation to Philadelphia.
Article from Aro Biotherapuetics
A biotechnology company pioneering the development of tissue-targeted genetic medicines has announced their three new executive leaders and headquarter relocation to Philadelphia.
Article from Aro Biotherapuetics